Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04469530
Title	Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors (AflacST1903)
Acronym	AflacST1903
Recruitment	Recruiting
Gender	both
Phase	Phase II
Variant Requirements	No
Sponsors	Emory University
Indications	sarcoma Advanced Solid Tumor Ewing sarcoma rhabdomyosarcoma osteosarcoma rhabdoid cancer
Therapies	Celecoxib + Cyclophosphamide + Etoposide + Sirolimus
Age Groups:	child \| adult
Covered Countries	USA

Filter rows:

Showing 1 to 5 of 5 entries

Facility	Status	City	State	Zip	Country	Details
Aflac Cancer & Blood Disorders Centers	RECRUITING	Atlanta	Georgia	30322	United States	Details
Children's Healthcare of Atlanta	RECRUITING	Atlanta	Georgia	30322	United States	Details
Children's Hospital of Pittsburgh of University of Pittsburgh Medical Center (UPMC)	RECRUITING	Pittsburgh	Pennsylvania	15224	United States	Details
Texas Children's Cancer Center	RECRUITING	Houston	Texas	77030	United States	Details
Washington University School of Medicine	RECRUITING	Saint Louis	Missouri	63110	United States	Details

Showing 1 to 5 of 5 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field